Analysis of the Application of MMP-9 Inhibitor in Skin Melanoma: Experimental Study
- 68 Downloads
Experiment on C57Bl/6 mice with modeled skin melanoma showed that selective inhibition of matrix metalloproteinase-9 increased lifetime and reduced the number of PCNA+ tumor cells and intensity of neoangiogenesis. Inhibition of matrix metalloproteinase-9 prevented tumor necrosis. The results suggest that matrix metalloproteinase-9 is involved not only in the regulation of extracellular matrix degradation, but also in the processes of cell proliferation and neoangiogenesis in skin melanoma. Therefore, this enzyme can be considered as a potential therapeutic target.
Key Wordsmatrix metalloproteinase-9 skin melanoma neoangiogenesis
Unable to display preview. Download preview PDF.
- 10.H. Mulder, J. Endocrinol., 10, 1530 (2011).Google Scholar